Communiqués Amicus Therapeutics, Inc.

Actions

FOLD

US03152W1099

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 14/06/2024			Varia. 5j.	Varia. 1 janv.
10,14 ^USD	-4,74 %		-1,27 %	-28,54 %

11/06	Transcript : Amicus Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 04:00 PM
30/05	AMICUS THERAPEUTICS, INC. : Wells Fargo Securities passe à l'achat	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	05/06	AQ
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product	04/06	AQ
Amicus Therapeutics: Q1 Earnings Snapshot	09/05	AQ
Amicus Therapeutics : 1Q24 Earnings Deck FINAL	09/05	PU
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates	09/05	AQ
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference	08/05	AQ
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024	01/05	AQ
Amicus Therapeutics : ESG Report	20/03	PU
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	20/03	AQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	04/03	AQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	01/03	AQ
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	28/02	AQ
Amicus Therapeutics : Fourth Quarter and Full Year 2023 Results Conference Call and Webcast	28/02	PU
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024	15/02	AQ
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti + Opfolda at the 20th Annual WORLDSymposium	09/02	AQ
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™	08/02	AQ
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024	01/02	AQ
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook	07/01	AQ
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01	AQ
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO	05/12	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Amicus Therapeutics, Inc.

Actions

FOLD

US03152W1099

Communiqués

Filtres